Skip to content

Home Search Authors Pakistan News Saved

SciRah

SciRah does not host or store research papers. Results come live from free, official scholarly APIs, and every paper links back to its original source.

Data sources

OpenAlex
Semantic Scholar
Crossref
CORE
arXiv
PubMed

Privacy policy Terms of service

H. Parekh · SciRah

Researcher profile · Semantic Scholar

H. Parekh

Share profile

H. Parekh — researcher profile on SciRah

h-index: 17
Works: 51
Citations: 965

Most-cited papers

Acquisition of taxol resistance via P-glycoprotein- and non-P-glycoprotein-mediated mechanisms in human ovarian carcinoma cells.
H. Parekh, Kenneth M. Wiesen, H. Simpkins
1997Biochemical Pharmacology100 citations
Semantic Scholar
Increased Expression of Dihydrodiol Dehydrogenase Induces Resistance to Cisplatin in Human Ovarian Carcinoma Cells*
H. Deng, H. Parekh, KuaChih Chow, H. Simpkins
2002Journal of Biological Chemistry95 citations Open access
Semantic Scholar
Synthesis, characterization, and cytotoxic studies of α-diimine/1,2-diamine platinum(II) and palladium(II) complexes of selenite and tellurite and binding of some of these complexes to DNA
H. Mansuri-Torshizi, R. Mital, T. Srivastava, H. Parekh +1 more
199184 citations
Semantic Scholar
Ubiquitous induction of resistance to platinum drugs in human ovarian, cervical, germ-cell and lung carcinoma tumor cells overexpressing isoforms 1 and 2 of dihydrodiol dehydrogenase
H. Deng, M. Adikari, H. Parekh, H. Simpkins
2004Cancer Chemotherapy and Pharmacology76 citations
Semantic Scholar
Dihydrodiol dehydrogenases regulate the generation of reactive oxygen species and the development of cisplatin resistance in human ovarian carcinoma cells
Jian-Li Chen, M. Adikari, Rajash Pallai, H. Parekh +1 more
2008Cancer Chemotherapy and Pharmacology74 citations Open access
Semantic Scholar
Cisplatin resistance in human cervical, ovarian and lung cancer cells
Jian-Li Chen, C. Solomides, H. Parekh, Fiona Simpkins +1 more
2015Cancer Chemotherapy and Pharmacology60 citations
Semantic Scholar
Synthesis, characterization, DNA binding, and cytotoxic studies of some mixed-ligand palladium(II) and platinum(II) complexes of alpha-diimine and amino acids.
R. Mital, T. Srivastava, H. Parekh, M. Chitnis
1991Journal of Inorganic Biochemistry58 citations
Semantic Scholar
The transport and binding of taxol.
H. Parekh, H. Simpkins
1997General Pharmacology53 citations
Semantic Scholar
Overexpression of sorcin, a calcium-binding protein, induces a low level of paclitaxel resistance in human ovarian and breast cancer cells.
H. Parekh, H. Deng, Khuram Choudhary, S. Houser +1 more
2002Biochemical Pharmacology51 citations
Semantic Scholar
RESISTANCE TO PLATINUM-BASED CHEMOTHERAPY IN LUNG CANCER CELL LINES
Jian-Li Chen, N. Emara, C. Solomides, H. Parekh +1 more
2010Cancer Chemotherapy and Pharmacology37 citations Open access
Semantic Scholar
The differential expression of cytokeratin 18 in cisplatin-sensitive and -resistant human ovarian adenocarcinoma cells and its association with drug sensitivity.
H. Parekh, Henry Simpkins
1995Cancer Research37 citations
Semantic Scholar
The CCAAT-box binding transcription factor, Nuclear Factor-Y (NF-Y) regulates transcription of human aldo-keto reductase 1C1 (AKR1C1) gene
Rajash Pallai, H. Simpkins, Jian-Li Chen, H. Parekh
2010Gene30 citations Open access
Semantic Scholar
Mycophenolate Mofetil Inhibits Hepatitis C Virus Replication in Human Hepatic Cells
L. Ye, Jie-Liang Li, Ting Zhang, Xu Wang +5 more
2012Virus Research29 citations Open access
Semantic Scholar
Cross-resistance to the synthetic retinoid CD437 in a paclitaxel-resistant human ovarian carcinoma cell line is independent of the overexpression of retinoic acid receptor-gamma.
Atul Kumar, D. Soprano, H. Parekh
2001Cancer Research27 citations
Semantic Scholar
Species-specific differences in taxol transport and cytotoxicity against human and rodent tumor cells. Evidence for an alternate transport system.
H. Parekh, Henry Simpkins
1996Biochemical Pharmacology21 citations
Semantic Scholar
The mutation Ser511Asn leads to N-glycosylation and increases the cleavage of high molecular weight kininogen in rats genetically susceptible to inflammation.
I. Isordia-Salas, R. Pixley, H. Parekh, S. Kunapuli +5 more
2003Blood19 citations
Semantic Scholar
NADPH-dependent enzyme-catalyzed reduction of aldophosphamide, the pivotal metabolite of cyclophosphamide.
H. Parekh, Norman E. Sládek
1993Biochemical Pharmacology17 citations
Semantic Scholar
Airway epithelial stem cell chimerism in cystic fibrosis lung transplant recipients
D. Hayes, R. Rayner, C. Hill, Alfahdah Alsudayri +6 more
2020Journal of Cystic Fibrosis15 citations Open access
Semantic Scholar
Cross-resistance and collateral sensitivity to natural product drugs in cisplatin-sensitive and -resistant rat lymphoma and human ovarian carcinoma cells
H. Parekh, H. Simpkins
2009Cancer Chemotherapy and Pharmacology15 citations
Semantic Scholar
Inverse Association Between the Quantity of Human Peripheral Blood CXCR5+IFN-γ+CD8+T cells with De Novo DSA Production in the First Year After Kidney Transplant
Jason M. Zimmerer, Matthew W Basinger, Bryce Ringwald, M. Abdel-Rasoul +6 more
2020Transplantation11 citations Open access
Semantic Scholar
Thromsbospondin-1 binds to the heavy chain of elastase activated coagulation factor V (FVaHNE) and enhances thrombin generation on the surface of a promyelocytic cell line.
I. Isordia-Salas, J. Manns, Irma M. Sáinz, H. Parekh +1 more
2005Thrombosis Research8 citations
Semantic Scholar
Synthesis, spectroscopic, cytotoxic, and DNA binding studies of binuclear 2,2'-bipyridine-platinum(II) and -palladium(II) complexes of meso-alpha,alpha'-diaminoadipic and meso-alpha,alpha'-diaminosuberic acids.
H. Mansuri-Torshizi, T. Srivastava, H. Parekh, M. Chitnis
1992Journal of Inorganic Biochemistry8 citations
Semantic Scholar
Expression of the cisplatin resistance phenotype in a human ovarian carcinoma cell line segregates with chromosomes 11 and 16.
B. Mirakhur, H. Parekh, Henry Simpkins
1996Cancer Research7 citations
Semantic Scholar
Modulation of thiol pools by vitamin K3 and its effect on survival of sensitive and resistant murine tumor cells
H. Parekh, Surendra J. Chavan, M. Chitnis
1991Anti-Cancer Drugs6 citations
Semantic Scholar
Differential Effect of Clofibrate on Adriamycin Cytotoxicity in P388 Murine Leukemia Cells Sensitive and Resistant to Adriamycin
M. Chitnis, H. Parekh, K. Satyamoorthy
1989Tumori6 citations
Semantic Scholar
Sensitization of Chronic Myeloid Leukemia Cells to Adriamycin Cytotoxicity by Clofibrate
H. Parekh, K. Satyamoorthy, S. Advani, M. Chitnis
1990Tumori5 citations
Semantic Scholar
Differential partitioning of Gαi1 with the cellular microtubules: a possible mechanism of development of Taxol resistance in human ovarian carcinoma cells
H. Parekh, M. Adikari, B. Vennapusa
2006Journal of Molecular Signaling4 citations Open access
Semantic Scholar
Differential Alteration of Cellular Lipids in Drug Sensitive and Resistant P388 Leukemia Cells by Clofibrate: Effects on Mitoxantrone Cytotoxicity
H. Parekh, M. Chitnis
1991Tumori4 citations
Semantic Scholar
Isolation of a hamster cDNA homologous to the mouse and human cyclin kinase inhibitory protein p27Kip1
H. Parekh, Kodandaram Pillarisetti, S. Kunapuli, H. Simpkins
1997Somatic Cell Genetics3 citations
Semantic Scholar
Impact of Donor Specific HLA Antibody Monitoring After Kidney Transplantation.
Swati Rao, M. Ghanta, Iris J. Lee, A. Gillespie +9 more
2014Clinical transplants2 citations
Semantic Scholar
Response of human chronic myeloid leukemia cells to mitoxantrone cytotoxicity: potentiation by bepridil, a calcium channel antagonist.
H. Parekh, J. Shallom, S. Advani, M. Chitnis
1991Neoplasma (Bratislava)2 citations
Semantic Scholar
Antineoplastic activity of mitoxantrone and its biological interactions in parental and multidrug resistant subline of P388 murine leukemia cells.
S. Chavan, H. Parekh, Manik P. Chitnis
1992Neoplasma (Bratislava)1 citations
Semantic Scholar
Antiproliferative Effects of Mitoxantrone in Adr-Sensitive and Adr-Resistant P388 Leukemia Cells Enhanced by Vitamin K3
H. Parekh, Surendra J. Chavan, M. Chitnis
1991Tumori1 citations
Semantic Scholar
Predictors of Relapse after Haploidentical Hematopoietic Progenitor Cell Transplantation (Haplo-HCT); A Single-Institution Experience
Michael Ozga, A. Schaefer, Ying Huang, H. Parekh +15 more
20200 citations Open access
Semantic Scholar
P152 Improved access to transplant via neutralization of rituximab by anti-rituximab antibodies
Todd Hertel, Paula L. Steller, P. Adams, H. Parekh
2019Human Immunology0 citations
Semantic Scholar
P016 Utility of higher resolution HLA antibody analysis in a sensitized kidney transplant recipient
H. Parekh, Todd Hertel, Adam Schoen, P. Adams +1 more
2019Human Immunology0 citations
Semantic Scholar
OR43 Unusual HLA-DRB1 and DRB3/4/5 typing association: A case study emphasizing the need for a rigorous QA/QC protocol to confirm assignment
N. Abdulwahab, Adam Schoen, H. Parekh
2019Human Immunology0 citations
Semantic Scholar
P122 To EDTA or not to EDTA – That should not be the question
H. Parekh, Aisha A. Eltayeb, N. Johnson, Audrey Ai Chin Lee +3 more
2018Human Immunology0 citations
Semantic Scholar
C3d deposition and antibody-mediated rejection after lung transplantation.
D. Hayes, H. Parekh, P. Baker
2018The Journal of Heart and Lung Transplantation0 citations
Semantic Scholar
P237 Specific pattern of non-specific ANTI-HLA antibody reactivity?
H. Parekh, J. Williamson, Todd Hertel, Aisha A. Eltayeb +4 more
20170 citations
Semantic Scholar
P158 Could chimerism testing on orthotopic liver transplant patients lead to earlier graft versus host disease intervention and in turn more effective outcomes
Annette Rearick, I. James, Sylvester M. Black, H. Parekh
20160 citations
Semantic Scholar
OR39: UTILITY OF ASSESSING THE C1Q BINDING ABILITY OF HLA ANTIBODIES IN MAXIMIZING DONOR POOLS AND PREDICTING RISK OF TRANSPLANT-RELATED MORBIDITY IN HEART TRANSPLANT
H. Parekh, Joseph L. Rudic, Phoebe W. Lai, Justin Lin +2 more
20140 citations
Semantic Scholar
P008 : AGGREGATED IgG CONTROL FOR PRONASE FC RECEPTOR (FcR) REMOVAL IN FLOW CROSSMATCH
S. Geier, Phi A. Lai, Justin Lin, Phoebe W. Lai +2 more
20140 citations
Semantic Scholar
P009 : REDUCING THE COST OF A ROSETTING METHOD WHICH IMPROVES FLOW CROSSMATCH SENSITIVITY BY REMOVING NEUTROPHILS AND MONOCYTES
Phi A. Lai, H. Parekh, Justin Lin, Phoebe W. Lai +2 more
20140 citations
Semantic Scholar
A Case Report of Synchronous Adrenal Pheochromocytoma and an Ipsilateral Renal Papillary Renal Cell Carcinoma Rype II-Possible Von Hippel-Lindau Disease
Hang-Cheng Zhou, D. Eun, H. Parekh, Heba Y Durra
20130 citations
Semantic Scholar
A Multi-Modailty Approach to Antibody Mediated Rejection
S. Geier, H. Parekh, Yan-Hui Li, R. Alvarez +5 more
20130 citations
Semantic Scholar
inflammation high molecular weight kininogen in rats genetically susceptible to The mutation S511N leads to N-glycosylation and increases the cleavage of
Yingzhang Lin, R. Sartor, W. Robert, H. Parekh +3 more
20130 citations
Semantic Scholar
Abstract 4990: Nuclear Factor-Y (NF-Y) regulates the transcription of the human aldo-keto reductase 1C1 (AKR1C1) gene*
Pallai Rajash, H. Simpkins, Jian-Li Chen, H. Parekh
20100 citations
Semantic Scholar
and 16 11 Ovarian Carcinoma Cell Line Segregates with Chromosomes Expression of the Cisplatin Resistance Phenotype in a Human
B. Mirakhur, H. Parekh, H. Simpkins
20060 citations
Semantic Scholar
Adenocarcinoma Cells and Its Association with Drug Sensitivity Cisplatin-sensitive and-resistant Human Ovarian The Differential Expression of Cytokeratin 18 in Updated
H. Parekh, H. Simpkins
20060 citations
Semantic Scholar

Frequent co-authors

Invite them to SciRah by sharing their profile.

H. Simpkins×14
Invite
H. Simpkins — researcher profile on SciRah
M. Chitnis×9
Invite
M. Chitnis — researcher profile on SciRah
Jian-Li Chen×5
Invite
Jian-Li Chen — researcher profile on SciRah
S. Geier×5
Invite
S. Geier — researcher profile on SciRah

×4

Invite

P. Adams — researcher profile on SciRah

Invite

H. Deng — researcher profile on SciRah

T. Srivastava×3

Invite

T. Srivastava — researcher profile on SciRah

Invite

M. Adikari — researcher profile on SciRah

Henry Simpkins×3

Invite

S. Kunapuli — researcher profile on SciRah

Invite

Todd Hertel — researcher profile on SciRah

Paula L. Steller×3

Invite

Paula L. Steller — researcher profile on SciRah